- Home
- RENB vs ZURA Comparison
RENB vs ZURA Comparison
Compare RENB & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RENB
- ZURA
- Stock Information
- Founded
- RENB 2011
- ZURA 2022
- Country
- RENB United States
- ZURA United States
- Employees
- RENB N/A
- ZURA N/A
- Industry
- RENB Biotechnology: Pharmaceutical Preparations
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RENB Health Care
- ZURA Health Care
- Exchange
- RENB Nasdaq
- ZURA Nasdaq
- Market Cap
- RENB 121.3M
- ZURA 115.6M
- IPO Year
- RENB N/A
- ZURA N/A
- Fundamental
- Price
- RENB $0.71
- ZURA $1.79
- Analyst Decision
- RENB
- ZURA Buy
- Analyst Count
- RENB 0
- ZURA 6
- Target Price
- RENB N/A
- ZURA $15.80
- AVG Volume (30 Days)
- RENB 1.8M
- ZURA 587.6K
- Earning Date
- RENB 02-12-2025
- ZURA 03-12-2025
- Dividend Yield
- RENB N/A
- ZURA N/A
- EPS Growth
- RENB N/A
- ZURA N/A
- EPS
- RENB N/A
- ZURA N/A
- Revenue
- RENB N/A
- ZURA N/A
- Revenue This Year
- RENB N/A
- ZURA N/A
- Revenue Next Year
- RENB N/A
- ZURA N/A
- P/E Ratio
- RENB N/A
- ZURA N/A
- Revenue Growth
- RENB N/A
- ZURA N/A
- 52 Week Low
- RENB $0.40
- ZURA $1.75
- 52 Week High
- RENB $5.25
- ZURA $6.35
- Technical
- Relative Strength Index (RSI)
- RENB 39.34
- ZURA 30.95
- Support Level
- RENB $0.70
- ZURA $1.86
- Resistance Level
- RENB $0.94
- ZURA $2.08
- Average True Range (ATR)
- RENB 0.14
- ZURA 0.19
- MACD
- RENB -0.03
- ZURA -0.03
- Stochastic Oscillator
- RENB 2.57
- ZURA 5.03
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
About ZURA Zura Bio Limited
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.